| Literature DB >> 8423870 |
N I Bohnen1, A Twijnstra, J Jolles.
Abstract
Recent evidence suggests that the vasopressin analogue desglycinamide-arginine8-vasopressin (DGAVP) might specifically benefit mild brain trauma patients. We investigated the effect of intranasal DGAVP treatment in 32 patients who had sustained a mild head injury for 3 months in a double-blind, placebo-controlled, matched-pairs study. DGAVP did not have a positive effect on cognitive recovery in this group of mildly affected patients.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8423870 DOI： 10.1212/wnl.43.1_part_1.103
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910